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1. Introduction 
When cognitive function declines at a rate greater than that expected based on the actual 
age, life circumstances and educational level, we define it as cognitive impairment (Blennow 
et al., 2006; Gauthier et al 2006). In the older generation, the neurodegenerative process is 
considered to occur several years before the development of clinically detectable cognitive 
impairment. Although aging is the most clear factor in the development of this disease 
process, several epidemiological studies have elucidated that cardiovascular risk factors, i.e., 
hyperlipidemia, hypertension, smoking and diabetes, are also associated with 
cerebrovascular disease processes that may deteriorate cognitive function and advance 
dementia (Casserly & Topol, 2004; Nash & Fillit, 2006; Whitmer et al., 2005). In this chapter, I 
would like to introduce the current positioning of cognitive impairment as a consequence of 
cardiovascular diseases as well as a form of cerebrovascular disease, to neurologists or 
psychiatrists as well as to general physicians or cardiologists. 
2. Cognitive impairment 
Currently, Alzheimer’s disease is the most common form of dementia or cognitive 
impairment, but less than 20% of dementia patients exhibit the isolated form of Alzheimer’s 
disease and around 50% of such patients exhibit a combination of Alzheimer’s disease and 
intracerebral vascular disease. By contrast, the isolated vascular type only contributes 20% 
(Meguro et al., 2002). Therefore, various problems related to metabolic syndrome, i.e., 
hypertension, hyperlipidemia, diabetes, and smoking habit, contribute to the development 
or deterioration of cognitive impairment. 
3. Cardiovascular problems in cognitive impairment  
Furthermore, recent investigations have suggested that the incidence of cognitive 
impairment is higher in patients with congestive heart failure and that treatment for left 
ventricular (LV) systolic dysfunction may prevent or delay the development of dementia in 
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elderly patients (Zuccala et al., 2003, 2005). An Italian investigation indicated that the incidence 
of congestive heart failure was markedly higher in subjects with Mini-Mental State 
Examination (MMSE) scores <24 (20.2%), compared with those with scores ≥24 (4.6%) 
(Zuccala et al., 2003). Also, the presence of cognitive impairment has been associated with 
increased in-hospital mortality in older patients with heart failure (Zuccala et al., 2005). These 
data may indicate that low cardiac output due to heart failure is related to the deterioration of 
cognitive function, although there have been no reports regarding the pathophysiology or 
etiology of heart failure in relation to cognitive impairment. Another investigation indicated an 
independent relation between the levels of b-type natriuretic peptide (BNP) and the degree of 
cognitive impairment in older subjects (>55years of age) with cardiovascular disease; despite 
the fact that the mechanism was unclear (Gunstad et al., 2006).    
In patients with heart failure, more than half of them, especially in females, showed normal or 
preserved LV ejection fraction (EF), i.e., exhibited heart failure resulting from LV diastolic 
dysfunction (Hogg et al. ,2004). Also, in heart failure patients with cardiovascular risk factors, 
i.e., hyperlipidemia, hypertension, smoking and diabetes, heart failure with preserved EF is 
also common. Therefore, we evaluated the relationship between LV diastolic dysfunction and 
cognitive impairment in Japanese patients with cardiovascular diseases (Suwa & Ito, 2009).   
In our study, patients were divided into 2 groups; those patients with normal cognitive 
function or mild cognitive impairment (MMSE>=24; n=68: group N) and those with 
depressed cognitive function (MMSE<24, n=13). Diastolic function was evaluated based 
upon the ratio of the early diastolic mitral flow velocity (E) by pulse-wave Doppler 
echocardiography to the early diastolic mitral annular myocardial velocity (e’) by tissue 
Doppler echocardiography (Diastolic Doppler index: E/e’).  BNP was also evaluated as an 
index of heart failure. Consequently, in depressed cognitive function, diastolic Doppler 
index, E/e’, was deteriorated (6.1±1.3 vs. N: 4.6±1.3, p<0.0003) and BNP was higher 
(137±142 pg/ml vs. N: 60±49 pg/ml, p<0.007), compared with those with normal cognitive 
function. Furthermore, the number of patients with diabetes was also higher in depressed 
cognitive function than in normal cognitive function (46% vs. N: 18%). From these studies 
evaluating the relation between cardiac and cognitive function, heart failure due to LV 
systolic and diastolic dysfunction can affect the development and the deterioration of 
cognitive impairment. 
 
Poor cerebral circulation: Left ventricular systolic dysfunction 
Left ventricular diastolic dysfunction    
Stroke: Atrial fibrillation, Atherosclerotic vascular 
diseases including of carotid artery stenosis 
Deep white matter hyperintensity 
 in brain MRI: 
Atherosclerotic abnormalities, due to 
hypertension, diabetes, hyperlipidemia, and 
smoking 
Hippocampal atrophy in brain: Senile process 
MRI: magnetic resonance imaging 
Table 1. Relationship between cardiovascular abnormalities and cerebrovascular diseases 
affecting the decline of cognitive function 
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The occurrence of atrial fibrillation (AF) is a risk of stroke, and stroke increases the risk of 
cognitive decline and dementia. Therefore, AF has been reported to be associated with 
cognitive decline and dementia (Jozwiak et al., 2006). Recently, even in stroke-free patients it 
has been shown that AF is a risk for cognitive impairment and hippocampal atrophy 
(Knecht et al., 2008). For these reasons, it was considered that AF was associated with 
abnormalities of hemostasis, endothelial damage, platelet dysfunction, and low cardiac 
output.  
As another measurable index in the vascular system, the ankle to brachial index is also 
related to incidence of total dementia, vascular dementia and Alzheimer’s disease, especially 
in carriers of the apolipoprotein E gene abnormality (Laurin et al. 2007).  
4. Common interest between cardiovascular and cerebrovascular diseases  
Brain magnetic resonance imaging is conducted to screen for cerebrovascular disease as well 
as cerebral disease, and hyperintensities in the deep white matter on T2-weighted images 
can be incidentally detected in 10-20% in adults aged 64 to 94% at age 82 in the general 
population (Fig.1 and Fig.2). At present, these white matter lesions are related to chronic 
hypoperfusion and disruption of the blood brain barrier due to small vessel disease in the 
lesion area (Debette & Markus, 2010). Also, white matter hyperintensities are more common 
in patients with cerebrovascular disease as well as cardiovascular disease, with risk factors 
affecting atherosclerosis, inclusive of  hypertension (Hajjar et al., 2011). Furthermore, meta-
analysis reveals that the white matter lesions predict an increased risk of stroke, dementia, 
and death. Although data that treatment for these risk factors reduces the progression of 
white matter hyperintensities are limited, it is also reported that antihypertensive therapy 
reduced the progression in patients with stroke (Saxby et al., 2008).  Therefore, white matter 
hyperintensities may be important markers to not only detect the risk of stroke and 
dementia but also diagnose the atherosclerosis in cerebro-cervical vascular system. The 
progression of white matter lesions is independently related to baseline cerebral lesion, 
higher age, hypertension, and current smoking. Also, atherosclerotic processes in the carotid 
artery, connecting to the cerebral artery, are associated with the cerebral small vessel disease 
(Romero et al., 2009). 
Modified Mini-Mental State Examination scale falls more according to the worsening of 
white matter grade (prominently in grade Two +). (Fig.3. Longstreth et al. 2005)  (with 
permission, License No.2776831264727) 
To date, some angiotensin receptor blockers have been reported to significantly reduce the 
incidence and progression of Alzheimer’s disease and dementia, compared with the use of 
angiotensin converting enzyme inhibitors or other cardiovascular drugs, in a predominant 
male population (Saxby et al., 2008). Therefore, when prescribing antihypertensive drugs we 
may have to consider the contribution of such medicines. 
At present, the CHADS2 score is widely used to validate the risk for stroke in patients with 
AF. A newer clinical study has shown that the CHADS2 score is useful to predict ischemic 
stroke in patients with stable coronary artery disease, even in those without baseline atrial 
fibrillation (Welles et al., 2011) 
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Fig. 1. Brain magnetic resonance imaging on T2 weighted images obtained from a 77 year 
old female without cognitive impairment and being under medication for hypertension. 
These images show somewhat brain atrophy but no white matter hyperintensities. 
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Fig. 2. White matter hyperintensities on brain magnetic resonance imaging from a 73 year 
old female with advanced cognitive impairment (score 18 on MMSE). Extensive 
hyperintensities can be seen in deep white matter, especially in periventricular region. She is 
under medication for hypertension and hyperlipidemia 
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Fig. 3. Scores on modified Mini-Mental State Examination (vertical axis) for each year of 
study from initial to follow-up brain MRI scans (horizontal axis) by groups of participants 
(people aged 65 years and older) defined by worsening grade of white matter hyperintensity 
(three grade: None, grade One, and grade Two+).  
Left ventricular systolic dysfunction: Low left ventricular ejection fraction 
Left ventricular diastolic dysfunction: Reduced e’, Increased E/e’ ratio 
B-type natriuretic peptide (BNP): Increased BNP or N-terminal pro-BNP 
Rhythm disturbance: Development of atrial fibrillation 
Ankle-brachial index (ABI): Low ABI  
Carotid ultrasonography Internal carotid artery stenosis 
e’: early diastolic mitral annular myocardial velocity by tissue Doppler echocardiography 
E: early diastolic mitral flow velocity by pulse-wave Doppler echocardiography   
Table 2. Cardiovascular indexes possibly to detect cognitive impairment  
5. Relationship between echocardiographic parameters and age  
Currently, LV diastolic function is evaluated based upon the following indices. Using pulse-
wave Doppler echocardiography, the ratio of E velocity and the late diastolic transmitral flow 
velocity (A): (E/A ratio), and early diastolic flow deceleration time are measured. By tissue 
Doppler echocardiography of mitral annular motion, e’ myocardial velocity can be evaluated. 
Also, diastolic function was evaluated by the diastolic Doppler index (E/e’), and this index is 
also useful to evaluate LV end-diastolic pressure or left atrial pressure in patients with heart 
failure with depressed or normal LV EF (Ommen et.al., 2000).  
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Among the healthy subjects, the previous reports have evaluated the changes with age in 
various parameters. LV systolic function, obtained from LV EF by standard 
echocardiography or LV myocardial performance index using Doppler echocardiography, 
have shown minimum increments with age.  However, LV diastolic function declined with 
age on echocardiographic parameters, i.e., E/A ratio and e’ velocity decreased, and E/e’ 
ratio increased (Munagala et al., 2003). Furthermore, LV wall thickness and LV mass 
increased gradually with age, and suggested depression of LV myocardial compliance 
(Daimon et al., 2008).  
In some reports discussing the relationship between cognitive impairment and 
cardiovascular dysfunction, LV diastolic function was depressed with the deterioration of 
cognitive function, which may be more progressive than that with aging alone (Hogg et al. 
,2004). Furthermore, in patients with heart failure, cognitive function is depressed, but there 
is no clear data as to whether LV systolic function is depressed with the decline of cognitive 
function and its decline is improved with the correction of systolic dysfunction. 
6. Conclusion 
While age is the most significant contributing factor to the development of cognitive 
impairment, several epidemiological studies have elucidated that cardiovascular risk 
factors, i.e., hyperlipidemia, hypertension, smoking and diabetes contribute to the 
deterioration of cognitive function. Furthermore, LV systolic and diastolic dysfunction, have 
been reported to cause cognitive impairment, likely as a result of the development of poor 
cerebral perfusion. Brain white matter hyperintensitiy and thromboembolic stroke due to 
atherosclerotic factors and atrial fibrillation are also related to producing cognitive 
impairment. Therefore, doctors and medical professionals, who are involved with medical 
treatment for cerebrovascular and cardiovascular diseases must keep in mind that 
atherosclerotic disease processes are also related to the development of cognitive 
impairment and progression of dementia.   
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